By Nana Karikari, Senior Global Affairs Correspondent
A rare and lethal strain of the Ebola virus is spreading rapidly across central Africa, triggering an international health emergency and exposing severe deficiencies in the global medical arsenal. The World Health Organization warned Wednesday that a viable vaccine for this specific species could take up to nine months to deploy, leaving local health systems to combat the mounting crisis with highly limited tools.
The outbreak, fueled by the rare Bundibugyo species of the virus, has shattered a decade-long absence of the strain. First discovered in 1976 in what is now the Democratic Republic of Congo and believed to have originated in bats, Ebola is an old foe, but this particular variant brings unique challenges. Unlike the more common Zaire strain, which devastated West Africa a decade ago and for which an approved vaccine exists, the Bundibugyo species has no approved vaccine or targeted therapeutic drugs. While historically less deadly than other species, the regulatory and logistical vacuum leaves an unstable, conflict-ridden region highly vulnerable to a pathogen that historically kills about a third of those it infects.
Escalating Toll and Detection Gaps
The scale of the crisis has rapidly outpaced early official tallies. WHO Director-General Dr. Tedros Adhanom Ghebreyesus announced that authorities have logged 600 suspected cases and 139 suspected deaths. The numbers are expected to surge further due to significant delays in early detection.
Official laboratory confirmations stand at 51 cases in the Democratic Republic of Congo and two in neighboring Uganda. However, epidemiological projections suggest the official data represents only a fraction of the true footprint. Modelling from the MRC Centre for Global Infectious Disease Analysis at Imperial College London indicates substantial under-detection, noting that the current outbreak is “larger than currently ascertained” and that its “true magnitude remains uncertain,” with a caseload potentially already exceeding 1,000.
The disease is believed to have entered the human population weeks before its formal detection. The first known case was a nurse in Bunia, the provincial capital of DRC’s Ituri province, who developed symptoms and died on April 24. Her body was subsequently repatriated to Mongwalu, one of two gold-mining hubs that have since become the epicenters of the epidemic. Health officials believe the virus began spreading silently months ago, amplified by a “super-spreader event,” possibly a funeral, in early May.
Regional Dissemination and Border Controls
The geographic trajectory of the virus highlights its potential for regional destabilization. From its epicenter in northeastern DRC, the virus has moved into North Kivu and South Kivu provinces, and a case has been detected in Goma, a strategic transit city of 850,000 residents currently controlled by Rwandan-backed rebels.
International transmission has already begun. Two cases were confirmed in the Ugandan capital of Kampala among individuals who had traveled from the DRC; one has since died. Dr. Anne Ancia, a WHO physician, emphasized the scope of the threat, stating:
“The more we are investigating this outbreak, the more we realise that it has already disseminated at least a little bit across border and also in other provinces.”
The regional response has been swift but disruptive. Rwanda has closed its borders with the DRC, while several African nations have tightened border screenings. In Uganda, public health officials have instructed citizens to alter foundational social customs, advising the population to avoid hugging and shaking hands.
In Bunia, local residents are acutely aware of the shifting realities. Araali Bagamba, a local lecturer, noted that the general population recognizes the danger. “For the last three days I haven’t shaken anyone’s hand and I observe that within the general population,” she said. “It’s our habit to shake hands all the time… [but] the habit has changed.” Bagamba added that many “believe it will get worse before it gets better” because the initial symptoms were not recognized as Ebola. This fear is echoed throughout the local population. A resident identifying himself only as Bigboy reported that communities are deeply frightened and attempting basic precautions, though they lack specialized equipment. Another local, Alfred Giza, noted that while public awareness is growing, residents are still waiting for basic protective supplies like face masks and remain unsure of how to safely handle an infection within their homes.
Africa CDC Invokes Emergency Powers for Continental Security
Recognizing the severe risk posed by cross-border mining mobility and intense population transit, the Africa Centres for Disease Control and Prevention officially declared the Bundibugyo outbreak a Public Health Emergency of Continental Security.
This statutory declaration grants the institution mandate-level authority to lead and unify the healthcare defense across member states.
Africa CDC Director General Dr. Jean Kaseya emphasized the indivisible nature of the continent’s safety, cutting short his attendance at the World Health Assembly in Geneva to direct operations directly on the ground. The agency has deployed multidisciplinary medical experts and internally mobilized $2 million to reinforce fragile regional networks. Operations are moving under the unified “4 Ones” architecture, establishing a singular team, plan, budget, and monitoring framework alongside the WHO and UNICEF to aggressively disrupt regional lines of transmission.
West African Vigilance and Ghana’s Preventive Stance
The geographic movement of the virus has put West African nations on high alert, drawing heavily from institutional memories of the devastating 2014–2016 epidemic. In Accra, the Ghanaian Ministry of Health issued a nationwide alert activating comprehensive Ebola preparedness measures. While authorities confirmed that Ghana has recorded zero suspected or confirmed cases of Ebola, the state has initiated mandatory health screenings at all airports, seaports, and land border crossings.
Ghana’s preventive framework specifically targets travelers arriving from the affected central and eastern African zones. The Ministry of Health has paired border controls with rapid response training for local medical staff and is accelerating the recruitment of thousands of preventive and community health professionals. This aggressive defensive posture aims to shield the population from external introduction while fortifying primary clinical defenses before an active domestic threat materialized.
Humanitarian and Security Complications
The public health response is unfolding inside a severe humanitarian crisis. Eastern DRC has been plagued by years of armed conflict, which has decimated medical infrastructure and displaced more than 100,000 people in Ituri province alone. This high level of insecurity induces constant population movements, accelerating the potential spread of the virus.
The region also hosts 11,000 refugees fleeing violence in South Sudan, alongside thousands of transient laborers working in informal gold mines. “WHO assesses the risk of the epidemic as high at the national and regional levels and low at the global level,” Tedros explained, noting that the security situation directly hinders surveillance. Health facilities cannot maintain stable diagnostics or care when medical personnel are forced to flee militant violence.
Diagnoses are further complicated by the fact that the initial symptoms of Ebola—fever, headache, and fatigue—closely mimic malaria and typhoid, illnesses endemic to the region. As the virus progresses, it causes vomiting, diarrhea, and can lead to organ failure and severe internal and external bleeding. Transmission occurs via direct contact with infected bodily fluids or broken skin.
The international implications were highlighted over the weekend when an American citizen, believed to be missionary medical doctor Peter Stafford, was evacuated to Germany after developing symptoms. The US Centers for Disease Control and Prevention confirmed it is also evacuating at least six other Americans exposed to the virus to quarantine facilities in Germany and the Czech Republic for symptom monitoring.
Overwhelmed Frontlines and Resource Scarcity
On the ground, local health facilities are rapidly buckling under the influx of patients. While personal protective equipment has begun arriving, frontline workers report they are still operating without sufficient safeguards, and medical personnel are already among the dead. One local man detailed the speed of the crisis to reporters, explaining that infected individuals are dying rapidly and noting plainly that Ebola has tortured the region.
The Red Cross warned that the conditions for an uncontrollable escalation are fully present: delayed identification, community information gaps, and exhausted health systems. Trish Newport, an emergency programme manager for Médicins Sans Frontières, described a gridlocked medical response, noting that health facilities are reporting a total depletion of capacity:
“‘We are full of suspect cases. We don’t have any space.’ This gives you a vision of how crazy it is right now.”
The primary operational objective has shifted entirely toward containment. Chikwe Ihekweazu, the WHO emergencies lead, stated that access constraints, including frequently canceled flights, continue to impede the delivery of diagnostic tests and basic medical supplies to Ituri. “Our absolute priority now is to identify all the existing chains of transmission,” Ihekweazu said. “That will then enable us to really define the scale of the outbreak and be able to provide care.”
The Nine-Month Vaccine Timeline
The structural hurdle of this outbreak rests on the genetics of the virus itself. The Bundibugyo species has only caused two recorded outbreaks since its discovery—in Uganda in 2007 and the DRC in 2012. Because of its rarity, pharmaceutical development has lagged far behind the Zaire strain, which infected 28,600 people and killed 11,325 across West Africa between 2014 and 2016.
Dr. Vasee Moorthy, a leading WHO research advisor, stated that two candidate vaccines are under evaluation, though neither has entered clinical trials. The most advanced candidate utilizes the same viral vector platform as the existing Zaire vaccine.
“This needs to be prioritised as the most promising Bundibugyo candidate vaccine,” Moorthy explained. However, he clarified that based on current manufacturing parameters, it is “likely to take six to nine months” before doses are ready for deployment.
A second candidate vaccine relies on the chimp adenovirus platform developed by Oxford University, famously utilized for the AstraZeneca Covid-19 vaccine. While manufacturing is underway, Moorthy cautioned that there is currently no animal data to prove its efficacy against Bundibugyo. Doses could potentially enter clinical trials within two to three months, but Moorthy emphasized that “there is a lot of uncertainty,” and progression remains strictly contingent on the outcomes of upcoming animal trials.
Geopolitical Tensions and Institutional Defense
The escalating crisis has also reignited friction between global powers and the international health agency. On Sunday, the WHO officially declared the outbreak a Public Health Emergency of International Concern, following an emergency committee review that concluded the situation did not yet constitute a pandemic emergency.
The declaration drew immediate criticism from Washington. US Secretary of State Marco Rubio stated the WHO was “a little late” in identifying and reacting to the epidemic. The critique carries deep political undertones, following the Trump administration’s formal withdrawal of the United States from the WHO earlier this year.
Tedros dismissed the American criticism during Wednesday’s briefing, attributing the remarks to an insufficient grasp of international health frameworks and the limits of global intervention.
“Maybe on what the secretary said, it could be from a lack of understanding of how IHR [international health regulations] works, and the responsibilities of WHO and other entities. We don’t replace the country’s work, we only support them. We should appreciate what was done so fast in a highly complex setting.”
The cash-strapped agency has released nearly $4 million from its emergency reserves to anchor the initial response, but officials acknowledge that significantly more capital will be required.
A Delicate Path to Containment
The divergence between global administrative debates and the ground realities in central Africa highlights the immense difficulty of managing a modern epidemic in a conflict zone. While political figures debate the timeline of the international declaration, local authorities face the immediate challenge of tracking transmission lines across volatile borders. Ultimately, the trajectory of the outbreak depends less on institutional friction and more on the speed with which basic isolation materials can reach overwhelmed hospitals, a task that remains fraught with logistical peril as the region waits for a medical breakthrough.
